Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease

DNA duplication associated with Charcot-Marie-Tooth disease type 1A

Lupski, J. R., de Oca-Luna, R. M., Slaugenhaupt, S., Pentao, L., Guzzetta, V., Trask, B. J., Saucedo-Cardenas, O., Barker, D. F., Killian, J. M., Garcia, C. A., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90613-4 · Cited by 1,333

Ascorbic acid: much more than just an antioxidant

Arrigoni, O., & De Tullio, M. C. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(01)00235-5 · Cited by 984

Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation

Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947

Genetic and clinical aspects of Charcot‐Marie‐Tooth's disease

Skre, H. (1974) · Clinical Genetics · doi:10.1111/j.1399-0004.1974.tb00638.x · Cited by 906

Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a)

Raeymaekers, P., Timmerman, V, Nelis, E., De Jonghe, P., Hoogenduk, J. E., Baas, F., Barker, D. F., Martin, J. J., De Visser, M., Bolhuis, P. A., et al. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90055-w · Cited by 607

Deletion, But Not Antagonism, of the Mouse Growth Hormone Receptor Results in Severely Decreased Body Weights, Insulin, and Insulin-Like Growth Factor I Levels and Increased Life Span

Coschigano, K. T., Holland, A. N., Riders, M. E., List, E. O., Flyvbjerg, A., & Kopchick, J. J. (2003) · Endocrinology · doi:10.1210/en.2003-0374 · Cited by 510

The gene for the peripheral myelin protein PMP–22 is a candidate for Charcot–Marie–Tooth disease type 1A

Patel, P. I., Roa, B. B., Welcher, A. A., Schoener-Scott, R., Trask, B. J., Pentao, L., Snipes, G. J., Garcia, C. A., Francke, U., Shooter, E. M., et al. (1992) · Nature Genetics · doi:10.1038/ng0692-159 · Cited by 499

Estimation of the Mutation Frequencies in Charcot-Marie-Tooth Disease Type 1 and Hereditary Neuropathy with Liability to Pressure Palsies: A European Collaborative Study

Nelis, E., & Van Broeckhoven, C. (1996) · European Journal of Human Genetics · doi:10.1159/000472166 · Cited by 431

Identical point mutations of PMP–22 in Trembler–J mouse and Charcot–Marie–Tooth disease type 1A

Valentijn, L. J., Baas, F., Wolterman, R. A., Hoogendijk, J. E., van den Bosch, N. H. A., Zorn, I., Gabreëls-Festen, A. A. W. M., de Visser, M., & Bolhuis, P. A. (1992) · Nature Genetics · doi:10.1038/ng1292-288 · Cited by 422

Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation.

Eldridge, C. F., Bunge, M. B., Bunge, R. P., & Wood, P. M. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.2.1023 · Cited by 399

Oxidative stress and neurodegeneration: where are we now?

Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614

Diagnosis, natural history, and management of Charcot–Marie–Tooth disease

Pareyson, D., & Marchesi, C. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70110-3 · Cited by 621

Vitamin C: Update on physiology and pharmacology

Mandl, J., Szarka, A., & Bánhegyi, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00282.x · Cited by 451

Clinical implications of genetic advances in Charcot–Marie–Tooth disease

Rossor, A. M., Polke, J. M., Houlden, H., & Reilly, M. M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.179 · Cited by 358

Reliability and validity of the CMT neuropathy score as a measure of disability

Shy, M. E., Blake, J., Krajewski, K., Fuerst, D. R., Laura, M., Hahn, A. F., Li, J., Lewis, R. A., & Reilly, M. (2005) · Neurology · doi:10.1212/01.wnl.0000156517.00615.a3 · Cited by 357

Regulation of the epigenome by vitamin C

Young, J. I., Züchner, S., & Wang, G. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034228 · Cited by 319

Signals to promote myelin formation and repair

Taveggia, C., Feltri, M. L., & Wrabetz, L. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.37 · Cited by 286

PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2

Inoue, K. (2005) · Neurogenetics · doi:10.1007/s10048-004-0207-y · Cited by 285

The PMP22 Gene and Its Related Diseases

Li, J., Parker, B., Martyn, C., Natarajan, C., & Guo, J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8370-x · Cited by 280

Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders

Sebat, J., Levy, D. L., & McCarthy, S. E. (2009) · Trends in Genetics · doi:10.1016/j.tig.2009.10.004 · Cited by 260

Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients

Lee, S., Bazick, H., Chittoor-Vinod, V., Al Salihi, M. O., Xia, G., & Notterpek, L. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.10.021 · Cited by 41